Filed by Enzon Pharmaceuticals, Inc.
Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant
to Rule 14a-12 of the Securities Exchange Act of 1934.
| Commission File No. 000-12957 | ||
| Subject Company: | Enzon Pharmaceuticals, Inc. | |
| NPS Pharmaceuticals, Inc. | ||
The following materials were used by executives of Enzon Pharmaceuticals, Inc. (“Enzon”) in connection with the announcement of the proposed business combination between Enzon and NPS Pharmaceuticals, Inc.
| * | Subject to stockholder and regulatory approvals and other customary closing conditions. |
